These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37662681)

  • 1. Retracted: Effects of Butylphthalide Sodium Chloride Injection Combined with Edaravone Dexborneol on Neurological Function and Serum Inflammatory Factor Levels in Sufferers Having Acute Ischemic Stroke.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9869475. PubMed ID: 37662681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Butylphthalide Sodium Chloride Injection Combined with Edaravone Dexborneol on Neurological Function and Serum Inflammatory Factor Levels in Sufferers Having Acute Ischemic Stroke.
    Li K; Zhang Q; Lu X; Yao S
    J Healthc Eng; 2022; 2022():1509407. PubMed ID: 35463675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of edaravone dexborneol versus dl-3-n-butylphthalide for the treatment of acute ischemic stroke: a Chinese health care perspective.
    Li J; Cao W; Zhao F; Jin P
    BMC Public Health; 2024 Feb; 24(1):436. PubMed ID: 38347500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the neuroprotective effects of dl-3-n-butylphthalide and edaravone dexborneol on cerebral ischemic stroke rats.
    Zhang H; Wang L; Zhu B; Yang Y; Cai C; Wang X; Deng L; He B; Cui Y; Zhou W
    Eur J Pharmacol; 2023 Jul; 951():175801. PubMed ID: 37207969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edaravone Dexborneol Alleviates Cerebral Ischemic Injury via MKP-1-Mediated Inhibition of MAPKs and Activation of Nrf2.
    Zhang W; Yang H; Gao M; Zhang H; Shi L; Yu X; Zhao R; Song J; Du G
    Biomed Res Int; 2022; 2022():4013707. PubMed ID: 36110124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Efficacy of Butylphthalide in Combination with Edaravone in the Treatment of Acute Ischemic Stroke and the Effect on Serum Inflammatory Factors.
    Markers D
    Dis Markers; 2023; 2023():9761940. PubMed ID: 38125390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke: A Phase III, Randomized, Double-Blind, Comparative Trial.
    Xu J; Wang A; Meng X; Yalkun G; Xu A; Gao Z; Chen H; Ji Y; Xu J; Geng D; Zhu R; Liu B; Dong A; Mu H; Lu Z; Li S; Zheng H; Chen X; Wang Y; Zhao X; Wang Y;
    Stroke; 2021 Mar; 52(3):772-780. PubMed ID: 33588596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Efficacy and Short-Term Prognosis of Butylphthalide and Sodium Chloride Injection Compared to Edaravone in the Treatment of Patients with Acute Stroke.
    Yang D; Zhang M; Wang X; Zhang J
    Altern Ther Health Med; 2023 Oct; 29(7):370-375. PubMed ID: 37499159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Butylphthalide in Combination with Edaravone in the Treatment of Acute Ischemic Stroke and the Effect on Serum Inflammatory Factors.
    Li Y; Hong Z; Li S; Xie S; Wang J; Wang J; Liu Y
    Dis Markers; 2023; 2023():9969437. PubMed ID: 37082457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study.
    Shi F; He Z; Wang L; Su H; Han S
    Front Pharmacol; 2022; 13():938239. PubMed ID: 36330098
    [No Abstract]   [Full Text] [Related]  

  • 11. Edaravone Dexborneol Downregulates Neutrophil Extracellular Trap Expression and Ameliorates Blood-Brain Barrier Permeability in Acute Ischemic Stroke.
    Huang Y; Zhang X; Zhang C; Xu W; Li W; Feng Z; Zhang X; Zhao K
    Mediators Inflamm; 2022; 2022():3855698. PubMed ID: 36032782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial.
    Xu J; Wang Y; Wang A; Gao Z; Gao X; Chen H; Zhou J; Zhao X; Wang Y
    Stroke Vasc Neurol; 2019 Sep; 4(3):109-114. PubMed ID: 31709115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Edaravone dexborneol protects cerebral ischemia reperfusion injury through activating Nrf2/HO-1 signaling pathway in mice.
    Xu L; Gao Y; Hu M; Dong Y; Xu J; Zhang J; Lv P
    Fundam Clin Pharmacol; 2022 Oct; 36(5):790-800. PubMed ID: 35470467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edaravone Dexborneol Treatment Attenuates Neuronal Apoptosis and Improves Neurological Function by Suppressing 4-HNE-Associated Oxidative Stress After Subarachnoid Hemorrhage.
    Chen Q; Cai Y; Zhu X; Wang J; Gao F; Yang M; Mao L; Zhang Z; Sun B
    Front Pharmacol; 2022; 13():848529. PubMed ID: 35529450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: Efficacy of Fuyuan Xingshen Decoction Combined with Butylphthalide Sodium Chloride Injection in the Treatment of Acute Cerebral Infarction and Its Effect on Hemodynamics.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9754181. PubMed ID: 38093886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Edaravone dexborneol provides neuroprotective benefits by suppressing NLRP3 inflammasome-induced microglial pyroptosis in experimental ischemic stroke.
    Hu R; Liang J; Ding L; Zhang W; Liu X; Song B; Xu Y
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109315. PubMed ID: 36279668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of edaravone combined with DL-3-N-butylphthalide on the levels of tumor necrosis factor-alpha, interleukin-10, neuron-specific enolase and effect in patients with acute cerebral infarction.
    Shen QQ; Wang W; Wu H; Tong XW
    J Physiol Pharmacol; 2022 Jun; 73(3):. PubMed ID: 36302533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke.
    Qian Y; Lyu Y; Jiang M; Tang B; Nie T; Lu S
    Brain Behav; 2019 Dec; 9(12):e01438. PubMed ID: 31638334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of hybrids from optically active ring-opened 3-N-butylphthalide derivatives and 4-fluro-edaravone as potential anti-acute ischemic stroke agents.
    Jia J; Wu J; Ji D; Jiao W; Wang X; Huang Z; Zhang Y
    Bioorg Med Chem; 2022 Sep; 69():116891. PubMed ID: 35764031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new multi-parameter imaging platform for in vivo drug efficacy evaluation of ischemic stroke.
    Su D; Zhang R; Wang X; Ding Q; Che F; Zhang W; Wu W; Li P; Tang B
    Talanta; 2024 Jan; 266(Pt 2):125133. PubMed ID: 37659227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.